Probiotics and other key determinants of dietary oxalate absorption

Advances in Nutrition

Volumn 2, Issue 3, 2011, Pages 254-260

  Liebman, Michael ^a   Al Wahsh, Ismail A ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIC ACID DERIVATIVE; PROBIOTIC AGENT;

BACTERIUM; BIOAVAILABILITY; CHEMICALLY INDUCED DISORDER; DIET; HUMAN; HYPEROXALURIA; INTESTINE; INTESTINE ABSORPTION; METABOLISM; MICROBIOLOGY; PLANT; REVIEW; URINE; UROLITHIASIS;

BACTERIA; BIOLOGICAL AVAILABILITY; DIET; HUMANS; HYPEROXALURIA; INTESTINAL ABSORPTION; INTESTINES; OXALATES; PLANTS, EDIBLE; PROBIOTICS; UROLITHIASIS;

EID: 84864054841     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.000414     Document Type: Review

References (41)

1. Hodgkinson A. Oxalic acid in biology and medicine. New York: Academic Press; 1977.
2. Williams HE, Wandzilak TR. Oxalate synthesis, transport and hyperoxaluric syndromes. J Urol. 1989; 141: 742-7.
3. Robertson WG, Hughes H. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis: new evidence from studies in the Arabian peninsula. Scanning Microsc. 1993; 7: 391-402.
4. Rose GA. Introduction. In: Rose GA, ed. Oxalate metabolism in relation to urinary stone. London: Springer-Verlag; 1988. p. 1-3.
5. Liebman M, Chai W. Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr. 1997; 65: 1453-9.
6. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001; 59: 270-6.
7. Elder TD, Wyngaarden JB. The biosynthesis and turnover of oxalate in normal and hyperoxaluric subjects. J Clin Invest. 1960; 39: 1337-44.
8. Hatch M, Freel RW. Intestinal transport of an obdurate anion: oxalate. Urol Res. 2005; 33: 1-18.
9. Jaeger P, Robertson WG. Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol. 2004; 98: 64-71.
10. Holmes RP, Goodman HO, Assimos DG. Dietary oxalate and its intestinal absorption. Scanning Microsc. 1995; 9: 1109-20.
11. Noonan SC, Savage GP. Oxalate content of foods and its effect on humans. Asia Pac J Clin Nutr. 1999; 8: 64-74.
12. Grentz L, Massey LK. Contribution of dietary oxalate to urinary oxalate in health and disease. Topics Clin Nutr. 2002; 17: 60-70.
13. Holmes RP, Assimos DG. The impact of dietary oxalate on kidney stone formation. Urol Res. 2004; 32: 311-6.
14. Chai W, Liebman M. Assessment of oxalate absorption from almonds and black beans with and without the use of an extrinsic label. J Urol. 2004; 172: 953-7.
15. Albihn PBE, Savage GP. The bioavailability of oxalate from oca (oxalis tuberosa). J Urol. 2001; 166: 420-2.
16. Brinkley L, McGuire J, Gregory J, Pak CYC. Bioavailability of oxalate in foods. Urology. 1981; 17: 534-8.
17. Hanson CF, Frankos VH, Thompson WO. Bioavailability of oxalic acid from spinach, sugar beet fibre and a solution of sodium oxalate consumed by female volunteers. Food Chem Toxicol. 1989; 27: 181-4.
18. Earnest DL, Williams HE, Admirand WH. A physio-chemical basis for treatment of enteric hyperoxaluria. Trans Assoc Am Physicians. 1975; 88: 224-34.
19. Hanes DA, Weaver CM, Heaney RP, Wastney M. Absorption of calcium oxalate does not require dissociation in rats. J Nutr. 1999; 129: 170-3.
20. Massey LK. Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc. 2007; 107: 1191-4.
21. De O G Mendonca C, Martini LA, Baxmann AC, Nishiura JL, Cuppari L, Sigulem DM, Heilberg IP. Effects of an oxalate load on urinary oxalate excretion in calcium stone formers. J Ren Nutr. 2003; 13: 39-46.
22. Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. 2008; 87: 1262-7.
23. Brogren M, Savage GP. Bioavailability of soluble oxalate from spinach eaten with and without milk products. Asia Pac J Clin Nutr. 2003; 12: 219-24.
24. Liebman M, Murphy S. Low oxalate bioavailability from black tea. Nutr Res. 2007; 27: 273-8.
25. Balcke P, Zazgornik J, Sunder-Plassmann G, Kiss A, Hauser AC, Gremmel F, Derfler K, Stockenhuber F, Schmidt P. Transient hyperoxaluria after ingestion of chocolate as a high risk factor for calcium oxalate calculi. Nephron. 1989; 51: 32-4.
26. Nguyen NU, Henriet MT, Dumoulin G, Widmer A, Regnard J. Increase in calciuria and oxaluria after a single chocolate bar load. Horm Metab Res. 1994; 26: 383-6.
27. Liebman M, Costa G. Effect of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol. 2000; 163: 1565-9.
28. Savage GP, Charrier M, Vanhanen L. Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr. 2003; 57: 415-9.
29. Martensson L, Savage GP. Composition and bioavailability of oxalates in baked taro (Colocasia esculenta var. Schott) leaves eaten with cows milk and cows milk and coconut milk. Int J Food Sci Technol. 2008; 43: 2213-8.
30. Sidhu H, Enatska L, Ogden S, Williams WN, Allison MJ, Peck AB. Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reactionbased detection system. Mol Diagn. 1997; 2: 89-97.
31. Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet. 1998; 352: 1026-9.
32. Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 2008; 19: 1197-203.
33. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol. 2003; 44: 475-81.
34. Troxel SA, Sidhu H, Kaul P, Low RK. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol. 2003; 17: 173-6.
35. Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int. 2009; 103: 18-21.
36. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int. 2001; 60: 1097-105.
37. Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int. 2005; 68: 1244-9.
38. Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol. 2007; 2: 745-9.
39. Ferraz RR, Marques NC, Froeder L, Menon VB, Siliano PR, Baxmann AC, Heilberg IP. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients. Urol Res. 2009; 37: 95-100.
40. Okombo J, Liebman M. Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects. Urol Res. 2010; 38: 169-78.
41. Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010; 78: 1178-85.